Table 3 Process of diagnosis
From: Therapy resistant urticaria as a long-term symptom of an incomplete Schnitzler syndrome
DATE | DIAGNOSIS | THERAPY | |
|---|---|---|---|
12/2013 | Intolerance reaction (ACE-Inhibitors) | Corticosteroids, AH | Hives covering the whole body |
03/2014 | Chronic spontaneous urticaria | ||
05/2014 | AH | ||
08/2014 | Omalizumab | ||
10/2014 | AH | Augmented urticaria after meat consumption | |
06/2017 | Urticaria pigmentosa (particularly trunk) | ||
07/2017 | Cutaneous mastocytosis—skin biopsy | AH, Corticosteroids (Azathioprin as MG therapy) | No local findings |
04/2018 | Cutaneous mastocytosis—bone marrow biopsy IgM MGUS DD CSU | AH | Augmented hives |
05/2021 | Omalizumab | Arthralgia and urticaria | |
11/2021 | Omalizumab increased dose | Augmented hives | |
02/2022 | Schnitzler syndrome | AH | Augmented hives after vaccination, recurring fever |
03/2022 | Anakinra | Recession of hives, reaction at injection site, Return of hives after therapy discontinuation | |
04/2022 | Canakinumab | Complete remissions of symptoms |